9.3077
2.61%
-0.2723
전일 마감가:
$9.58
열려 있는:
$9.3
하루 거래량:
47,236
Relative Volume:
0.13
시가총액:
$609.23M
수익:
$512.35M
순이익/손실:
$-156.23M
주가수익비율:
-3.7082
EPS:
-2.51
순현금흐름:
$7.98M
1주 성능:
-10.63%
1개월 성능:
-18.30%
6개월 성능:
+58.40%
1년 성능:
+91.19%
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
9.315 | 609.23M | 512.35M | -156.23M | 7.98M | -2.51 |
ABT
Abbott Laboratories
|
112.48 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
BSX
Boston Scientific Corp
|
95.44 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
365.87 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
81.34 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.34 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2022-03-15 | 개시 | Craig Hallum | Buy |
2021-11-15 | 재개 | Morgan Stanley | Overweight |
2021-11-10 | 재개 | JP Morgan | Overweight |
2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
2021-03-08 | 개시 | Canaccord Genuity | Buy |
2021-03-08 | 개시 | Goldman | Buy |
2021-03-08 | 개시 | JP Morgan | Overweight |
2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
Where are the Opportunities in (BVS) - Stock Traders Daily
Bioventus CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Principal Financial Group Inc. Takes Position in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Inc. (NYSE:BVS) Shares Acquired by Jane Street Group LLC - Defense World
Bioventus (NYSE:BVS) Trading Down 5.9%Here's Why - MarketBeat
Bioventus: Amply Rewarded For Recent Progress (NASDAQ:BVS) - Seeking Alpha
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Bioventus completes divestiture of its Advanced Rehabilitation business - Yahoo Finance
Bioventus stock Buy rating reaffirmed, focus shifts to Ultrasonics and international growth - Investing.com India
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - The Manila Times
Bioventus Completes $20M Advanced Rehabilitation Business Sale to Accelmed Partners - StockTitan
Bioventus Inc. (NYSE:BVS) Shares Acquired by Barclays PLC - Defense World
Bioventus Inc. (NYSE:BVS) Shares Purchased by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes $1.01 Million Position in Bioventus Inc. (NYSE:BVS) - Defense World
Franklin Resources Inc. Makes New Investment in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc. (NYSE:BVS) Stock Position Lifted by State Street Corp - MarketBeat
State Street Corp Has $8.08 Million Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock By Investing.com - Investing.com Canada
Katrina J. Church Sells 2,535 Shares of Bioventus Inc. (NYSE:BVS) Stock - MarketBeat
Insider Selling: Bioventus Inc. (NYSE:BVS) CFO Sells $113,018.49 in Stock - MarketBeat
Bioventus SVP Anthony D’Adamio sells shares worth $61,579 By Investing.com - Investing.com Nigeria
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock - Investing.com
Shareholder lawsuit ends with $15 million settlement - The Business Journals
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year? - MSN
Medical Device Investors Get Final OK On $15M Deal - Law360
Bioventus Investors Get $15 Million Med Rebate Deal Approved - Bloomberg Law
Learn to Evaluate (BVS) using the Charts - Stock Traders Daily
Bioventus (NYSE:BVS) Upgraded to “Neutral” at JPMorgan Chase & Co. - Defense World
JP Morgan Upgrades Bioventus (BVS) - MSN
Bioventus (NYSE:BVS) Shares Gap UpHere's Why - MarketBeat
Bioventus (NYSE:BVS) Upgraded to Neutral at JPMorgan Chase & Co. - MarketBeat
Fmr LLC Acquires 166,014 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Fmr LLC Raises Position in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc. (NYSE:BVS) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Charles Schwab Investment Management Inc. Purchases 109,359 Shares of Bioventus Inc. (NYSE:BVS) - MarketBeat
Point72 Asset Management L.P. Makes New $788,000 Investment in Bioventus Inc. (NYSE:BVS) - MarketBeat
How to Take Advantage of moves in (BVS) - Stock Traders Daily
Jacobs Levy Equity Management Inc. Lowers Stake in Bioventus Inc. (NYSE:BVS) - MarketBeat
Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet - Yahoo Finance
Joint Pain Injection Market Expected to Reach Prominent Growth - openPR
Bioventus Inc (BVS) Stock Price Down 3.98% on Dec 4 - GuruFocus.com
Trading (BVS) With Integrated Risk Controls - Stock Traders Daily
Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.
Principal Financial Group Inc. Invests $210,000 in Bioventus Inc. (NYSE:BVS) - Defense World
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 258,756 Bioventus Inc. (NYSE:BVS) - MarketBeat
Segall Bryant & Hamill LLC Invests $4.52 Million in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus (BVS) Matches Q3 Earnings Estimates - MSN
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bioventus Inc 주식 (BVS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
CHURCH KATRINA J | SVP & Chief Compliance Officer |
Dec 23 '24 |
Sale |
10.53 |
2,535 |
26,694 |
47,264 |
D'Adamio Anthony | SVP & General Counsel |
Dec 23 '24 |
Sale |
10.53 |
5,848 |
61,579 |
109,578 |
자본화:
|
볼륨(24시간):